» Articles » PMID: 28774870

Relationship of Gastric Emptying or Accommodation with Satiation, Satiety, and Postprandial Symptoms in Health

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

The contributions of gastric emptying (GE) and gastric accommodation (GA) to satiation, satiety, and postprandial symptoms remain unclear. We aimed to evaluate the relationships between GA or GE with satiation, satiety, and postprandial symptoms in healthy overweight or obese volunteers (total = 285, 73% women, mean BMI 33.5 kg/m): 26 prospectively studied obese, otherwise healthy participants and 259 healthy subjects with previous similar GI testing. We assessed GE of solids, gastric volumes, calorie intake at buffet meal, and satiation by measuring volume to comfortable fullness (VTF) and maximum tolerated volume (MTV) by using Ensure nutrient drink test (30 ml/min) and symptoms 30 min after MTV. Relationships between GE or GA with satiety, satiation, and symptoms were analyzed using Spearman rank ( ) and Pearson () linear correlation coefficients. We found a higher VTF during satiation test correlated with a higher calorie intake at ad libitum buffet meal ( = 0.535, < 0.001). There was a significant inverse correlation between gastric half-emptying time (GE ) and VTF ( = -0.317, < 0.001) and the calorie intake at buffet meal ( = -0.329, < 0.001), and an inverse correlation between GE Tlag and GE25% emptied with VTF ( = -0.273, < 0.001 and = -0.248, < 0.001, respectively). GE was significantly associated with satiation (MTV, 0.234, < 0.0001), nausea ( 0.145, = 0.023), pain ( 0.149, = 0.012), and higher aggregate symptom score ( 0.132, = 0.026). There was no significant correlation between GA and satiation, satiety, postprandial symptoms, or GE. We concluded that GE of solids, rather than GA, is associated with postprandial symptoms, satiation, and satiety in healthy participants. A higher volume to comfortable fullness postprandially correlated with a higher calorie intake at ad libitum buffet meal. Gastric emptying of solids is correlated to satiation (volume to fullness and maximum tolerated volume) and satiety (the calorie intake at buffet meal) and symptoms of nausea, pain, and aggregate symptom score after a fully satiating meal. There was no significant correlation between gastric accommodation and either satiation or satiety indices, postprandial symptoms, or gastric emptying.

Citing Articles

Physiology and Pharmacology of Effects of GLP-1-based Therapies on Gastric, Biliary and Intestinal Motility.

Jalleh R, Marathe C, Rayner C, Jones K, Umapathysivam M, Wu T Endocrinology. 2024; 166(1).

PMID: 39568409 PMC: 11630531. DOI: 10.1210/endocr/bqae155.


The Possible Involvement of Glucagon-like Peptide-2 in the Regulation of Food Intake through the Gut-Brain Axis.

Baccari M, Vannucchi M, Idrizaj E Nutrients. 2024; 16(18).

PMID: 39339669 PMC: 11435434. DOI: 10.3390/nu16183069.


Precision medicine for obesity: current evidence and insights for personalization of obesity pharmacotherapy.

Anazco D, Acosta A Int J Obes (Lond). 2024; .

PMID: 39127792 DOI: 10.1038/s41366-024-01599-z.


The Efficacy of GLP-1 Analogues on Appetite Parameters, Gastric Emptying, Food Preference and Taste Among Adults with Obesity: Systematic Review of Randomized Controlled Trials.

Aldawsari M, Almadani F, Almuhammadi N, Algabsani S, Alamro Y, Aldhwayan M Diabetes Metab Syndr Obes. 2023; 16:575-595.

PMID: 36890965 PMC: 9987242. DOI: 10.2147/DMSO.S387116.


Gastric Emptying and Its Correlation With Weight Loss and Body Mass Index in Patients With an Intragastric Balloon: A Prospective Study With Six Years of Follow-Up.

Barrichello S, Ribeiro I, de Souza T, Galvao Neto M, Grecco E, Waisberg J Cureus. 2023; 14(12):e32599.

PMID: 36654650 PMC: 9840869. DOI: 10.7759/cureus.32599.


References
1.
Chial H, Camilleri C, Delgado-Aros S, Burton D, Thomforde G, Ferber I . A nutrient drink test to assess maximum tolerated volume and postprandial symptoms: effects of gender, body mass index and age in health. Neurogastroenterol Motil. 2002; 14(3):249-53. DOI: 10.1046/j.1365-2982.2002.00326.x. View

2.
le Roux C, Astrup A, Fujioka K, Greenway F, Lau D, Van Gaal L . 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial. Lancet. 2017; 389(10077):1399-1409. DOI: 10.1016/S0140-6736(17)30069-7. View

3.
Pi-Sunyer X, Astrup A, Fujioka K, Greenway F, Halpern A, Krempf M . A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. N Engl J Med. 2015; 373(1):11-22. DOI: 10.1056/NEJMoa1411892. View

4.
Karamanolis G, Caenepeel P, Arts J, Tack J . Association of the predominant symptom with clinical characteristics and pathophysiological mechanisms in functional dyspepsia. Gastroenterology. 2006; 130(2):296-303. DOI: 10.1053/j.gastro.2005.10.019. View

5.
Cummings D, Overduin J . Gastrointestinal regulation of food intake. J Clin Invest. 2007; 117(1):13-23. PMC: 1716217. DOI: 10.1172/JCI30227. View